New England Journal of Medicine: Vytorin-Cancer Link ‘Uncertain’

In a study, patients who took Vytorin had a higher risk of cancer than those who took a placebo. One analysis suggests the finding was a fluke. But an editorial in an influential journal says caution is warranted.